Elutia Inc. (ELUT)
NASDAQ: ELUT · Real-Time Price · USD
2.320
+0.220 (10.48%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Elutia Revenue
In the year 2024, Elutia had annual revenue of $24.38M, down -1.50%. Elutia had revenue of $5.47M in the quarter ending December 31, 2024.
Revenue (ttm)
$24.38M
Revenue Growth
-1.50%
P/S Ratio
2.77
Revenue / Employee
$477,941
Employees
51
Market Cap
94.51M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
ELUT News
- 4 days ago - Elutia Confirms No Material Impact from Global Tariffs - GlobeNewsWire
- 15 days ago - Elutia to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes - GlobeNewsWire
- 22 days ago - Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™ - GlobeNewsWire
- 24 days ago - Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope - GlobeNewsWire
- 6 weeks ago - Elutia Inc. (ELUT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out - GlobeNewsWire
- 2 months ago - Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025 - GlobeNewsWire